REG - Taseko Mines Limited - US$150 Million Bought Deal Financing

Taseko MinesAnnouncement

16/10/2025 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251016:nRSP7221Da&default-theme=true

RNS Number : 7221D  Taseko Mines Limited  16 October 2025

Taseko Mines Limited Announces US$150 Million Bought Deal Financing

The Base Shelf Prospectus is accessible, and the prospectus supplement will be
accessible within two business days, through SEDAR+

Vancouver, BC (October 15, 2025) Taseko Mines Limited (TSX: TKO; NYSE: TGB;
LSE: TKO) ("Taseko Mines", "Taseko" or the "Company") has announced today that
it has entered into an agreement with BMO Capital Markets and Canaccord
Genuity Corp., as co-lead managers, and National Bank Financial Inc., each as
joint bookrunners, on behalf of a syndicate of underwriters (the
"Underwriters"), pursuant to which the underwriters have agreed to purchase on
"bought deal" basis 37,100,000 common shares (the "Common Shares"), at a price
of US$4.05 per Common Share for gross proceeds of US$150,255,000 (the
"Offering"). The Company has granted the Underwriters an option, exercisable
at the offering price for a period of 30 days following the closing of the
Offering, to purchase up to an additional 15% of the Offering to cover
over-allotments, if any (the "Over-Allotment Option").

The Company intends to use the net proceeds of the Offering to repay
outstanding indebtedness under the Company's revolving credit facility and for
general corporate and working capital purposes.

The Offering is expected to close on or about October 22, 2025, subject to
certain customary closing conditions, including the receipt of all necessary
approvals of the Toronto Stock Exchange and the NYSE American.

In connection with the Offering, the Company will file a prospectus supplement
to its short form base shelf prospectus dated June 30, 2025 (the "Base Shelf
Prospectus"). The prospectus supplement will be filed with the securities
regulatory authorities in each of the provinces and territories of Canada,
except Québec and Nunavut, as well as with the U.S. Securities and Exchange
Commission (SEC) as part of an effective registration statement on Form F-10
under the U.S./Canada Multijurisdictional Disclosure System (the "Registration
Statement").

The Base Shelf Prospectus and Registration Statement are, and the prospectus
supplements will be, accessible on Taseko's issuer profile on SEDAR+ at
www.sedarplus.ca and on EDGAR at www.sec.gov. Copies of the Base Shelf
Prospectus, Registration Statement and prospectus supplements relating to the
Offering, when available, may be obtained upon request in Canada by contacting
BMO Nesbitt Burns Inc. ("BMO Capital Markets"), Brampton Distribution Centre
C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2
by telephone at 905-791-3151 Ext 4312 or by email at
torbramwarehouse@datagroup.ca, and in the United States by contacting BMO
Capital Markets Corp., Attn: Equity Syndicate Department, 151 W 42nd Street,
32nd Floor, New York, NY 10036, or by telephone at (800) 414-3627 or by email
at bmoprospectus@bmo.com. Before investing, prospective investors should read
the Base Shelf Prospectus, the prospectus supplements, when available, the
Registration Statement and the documents incorporated by reference therein.

This news release shall not constitute an offer to sell or the solicitation of
an offer to buy, nor shall there be any sale of the Common Shares in any
jurisdiction in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of that
jurisdiction.

For further information on Taseko, contact:

·   Investor enquiries Brian Bergot, Vice President, Investor Relations -
778-373-4554

Stuart McDonald

President and CEO

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of
applicable Canadian securities legislation, and "forward-looking statements"
within the meaning of the United States Private Securities Litigation Reform
Act of 1995 (collectively referred to as "forward-looking information"). The
use of any of the words "expect", "plan", "update" and similar expressions are
intended to identify forward-looking information or statements. These
statements include, but are not limited to, expectations about the likelihood
of completion of the Offering, the amount of funds to be raised, the intended
use of proceeds of the Offering, the anticipated closing date of the Offering
and the ability of the Company to secure the required stock exchange
acceptances and satisfy other applicable closing conditions for the Offering.
Though the Company believes the expectations expressed in its forward-looking
statements are based on reasonable assumptions, such statements are subject to
known and unknown risks, uncertainties and other factors that may cause the
Company's actual results, level of activity, performance or achievements to be
materially different from those expressed or implied by such forward-looking
statements.  For further information on Taseko and the assumptions and risks
related to Taseko's business and forward looking statements, investors should
review the Company's annual information form, annual MD&A and audited
financial statements filed by the Company under Canadian securities laws at
www.sedarplus.ca and included in the Company's annual report on Form 40-F
filed with the United States Securities and Exchange Commission at
www.sec.gov, together with the prospectus supplements and other continuous
disclosure filings made by the Company that have been filed at
www.sedarplus.ca and www.sec.gov and incorporated by reference into the
prospectus supplements.

No regulatory authority has approved or disapproved of the information
contained in this news release.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBSBDGSDBDGUL



            Copyright 2019 Regulatory News Service, all rights reserved